FREMONT, Calif., June 9 WaferGen Biosystems,Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art geneexpression, genotyping, cell biology and stem cell research systems, todayannounced that Kumar Kastury, Ph.D., vice president of assay development, willprovide a poster presentation on its SmartChip(TM) Real-Time PCR System at theCambridge Healthcare Institute's Ninth Annual Beyond Genome conference. Theconference will be held June 8-11, 2008, at the Fairmont Hotel in SanFrancisco.
WaferGen's poster presentation will be available on Wednesday, June 11thfrom 9:50 a.m. until 4:30 p.m. The presentation will include an overview ofthe company's novel whole genome, high-throughput SmartChip Real-Time PCRSystem, as well as data related to 100nL real-time PCR gene expression. TheSmartChip Real-Time PCR System can perform tens of thousands of nano-scalequantitative PCR (qPCR) assays in a single run, combining the screeningthroughput of microarrays with the sensitivity of qPCR in a single step.
WaferGen Biosystems, Inc. is a leader in the development, manufacture andsale of state-of-the-art systems for gene expression, genotyping, cell biologyand stem cell research for the life science and pharmaceutical industries.The company is actively developing its SmartChip(TM) product for the geneexpression and genotyping markets. SmartChip(TM) is being developed as thefirst whole genome, high throughput gene expression real-time polymerase chainreaction (PCR) platform and promises to deliver significant speed and costadvantages to researchers in the gene expression and genotyping markets.WaferGen currently markets its SmartSlide(TM) family of products to companiesand organizations involved in stem cell and cell biology research.SmartSlide(TM), which was launched in 2006, represents the first fluidicsintegrated micro-incubators enabling cell biology and stem cell research.Representative SmartSlide(TM) customers include Harvard University, MayoClinic, California Institute of Technology (CalTech), Abbott Labs, and theNational Institutes of Health (NIH).Contact: Vida Communication (on behalf of WaferGen) Stephanie Diaz (investors) Tim Brons (media) 415-675-7400 415-675-7402 email@example.com firstname.lastname@example.org
SOURCE WaferGen Biosystems, Inc.